Ann: Improved Neuronal Cell Survival in 3D Model of Alzheimer's, page-4

Thanks for the info Boffin. That sounds as though theres more work to be done.

I'm not entirely across where IXC is heading. I missed the AGM, so if there are otheres that can chime in about the future then that would be great.

The main previous focus of the company has been dropped, as I understand it, because of other drugs that are beneficial to reducing intercranial pressure and weight loss (often a main cause of the pressure).

The company did a capital return and has started new collaborations. Hopefully something comes of these...